Eastern Cooperative Oncology Group performance status grade of 0, 1 or 2;
Diagnosis of multiple myeloma;have received at least one prior line of therapy including Lenalidomide and a proteasome inhibitor.
Able to understand and comply with the requirements of the clinical protocol, voluntarily participate in the clinical trial, and sign informed consent.
You may not be if
Plasma cell leukemia , Waldenström's macroglobulinemia, POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes), or amyloidosis.
Active central nervous system involvement or exhibits clinical signs of meningeal involvement of multiple myeloma.
Prior treatment with any BCMA-targeted therapiy.
Active infecion.
Known allergies, hypersensitivity, or intolerance to the study drug or its excipients.